Piper Sandler analyst Korinne Wolfmeyer lowered the firm’s price target on Amyris to $2 from $2.50 and keeps a Neutral rating on the shares. The analyst views view China, travel retail, and trade down as key themes to watch in 2023 for the beauty and wellness sector.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMRS: